Cargando…
Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series
Pneumothorax is one of the most common symptoms in patients with lymphangioleiomyomatosis (LAM). However, current management strategies for patients with LAM who present with recurrent pneumothorax remain inadequate. Here, we describe the successful prevention of recurrent pneumothorax by sirolimus...
Autores principales: | Zhou, Li, Ouyang, Ruoyun, Luo, Hong, Ren, Siying, Chen, Ping, Peng, Yating, Liu, Ting, Liu, Guiqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150971/ https://www.ncbi.nlm.nih.gov/pubmed/30241551 http://dx.doi.org/10.1186/s13023-018-0915-2 |
Ejemplares similares
-
Lymphangioleiomyomatosis Presenting as Recurrent Pneumothorax
por: Odak, Mihir, et al.
Publicado: (2020) -
Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis
por: Sakurai, Teiko, et al.
Publicado: (2021) -
Sirolimus reduces the risk of pneumothorax recurrence in patients with lymphangioleiomyomatosis: a historical prospective self-controlled study
por: Cheng, Chongsheng, et al.
Publicado: (2022) -
Pulmonary lymphangioleiomyomatosis presenting as spontaneous pneumothorax treated with sirolimus - A case report
por: Verma, Ajay Kumar, et al.
Publicado: (2018) -
Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)